320 related articles for article (PubMed ID: 24209622)
1. Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.
Emerling BM; Hurov JB; Poulogiannis G; Tsukazawa KS; Choo-Wing R; Wulf GM; Bell EL; Shim HS; Lamia KA; Rameh LE; Bellinger G; Sasaki AT; Asara JM; Yuan X; Bullock A; Denicola GM; Song J; Brown V; Signoretti S; Cantley LC
Cell; 2013 Nov; 155(4):844-57. PubMed ID: 24209622
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of PI5P4Kα/β disrupts cell energy metabolism and selectively kills p53-null tumor cells.
Chen S; Chandra Tjin C; Gao X; Xue Y; Jiao H; Zhang R; Wu M; He Z; Ellman J; Ha Y
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34001596
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases.
Ma G; Duan Y; Huang X; Qian CX; Chee Y; Mukai S; Cui J; Samad A; Matsubara JA; Kazlauskas A; D'Amore PA; Gu S; Lei H
Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3935-43. PubMed ID: 27472081
[TBL] [Abstract][Full Text] [Related]
4. 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers.
Yang H; Shu Z; Jiang Y; Mao W; Pang L; Redwood A; Jeter-Jones SL; Jennings NB; Ornelas A; Zhou J; Rodriguez-Aguayo C; Bartholomeusz G; Iles LR; Zacharias NM; Millward SW; Lopez-Berestein G; Le XF; Ahmed AA; Piwnica-Worms H; Sood AK; Bast RC; Lu Z
Clin Cancer Res; 2019 Sep; 25(18):5702-5716. PubMed ID: 31391192
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.
Wortmann L; Bräuer N; Holton SJ; Irlbacher H; Weiske J; Lechner C; Meier R; Karén J; Siöberg CB; Pütter V; Christ CD; Ter Laak A; Lienau P; Lesche R; Nicke B; Cheung SH; Bauser M; Haegebarth A; von Nussbaum F; Mumberg D; Lemos C
J Med Chem; 2021 Nov; 64(21):15883-15911. PubMed ID: 34699202
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localizations of phosphatidylinositol 5-phosphate 4-kinases α and β are dynamic and independently regulated during starvation-induced stress.
Droubi A; Bulley SJ; Clarke JH; Irvine RF
Biochem J; 2016 Jul; 473(14):2155-63. PubMed ID: 27208178
[TBL] [Abstract][Full Text] [Related]
7. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
8. Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: A role for PIP4K2B in the regulation of E-cadherin expression.
Keune WJ; Sims AH; Jones DR; Bultsma Y; Lynch JT; Jirström K; Landberg G; Divecha N
Cancer Res; 2013 Dec; 73(23):6913-25. PubMed ID: 24127122
[TBL] [Abstract][Full Text] [Related]
9. Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.
Osman AA; Monroe MM; Ortega Alves MV; Patel AA; Katsonis P; Fitzgerald AL; Neskey DM; Frederick MJ; Woo SH; Caulin C; Hsu TK; McDonald TO; Kimmel M; Meyn RE; Lichtarge O; Myers JN
Mol Cancer Ther; 2015 Feb; 14(2):608-19. PubMed ID: 25504633
[TBL] [Abstract][Full Text] [Related]
10. Signalling: a new target for p53-null tumours.
Lokody I
Nat Rev Cancer; 2014 Jan; 14(1):8-9. PubMed ID: 24304875
[No Abstract] [Full Text] [Related]
11. Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.
Berge EO; Huun J; Lillehaug JR; Lønning PE; Knappskog S
Biochim Biophys Acta; 2013 Mar; 1830(3):2790-7. PubMed ID: 23246812
[TBL] [Abstract][Full Text] [Related]
12. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.
Gadhikar MA; Sciuto MR; Alves MV; Pickering CR; Osman AA; Neskey DM; Zhao M; Fitzgerald AL; Myers JN; Frederick MJ
Mol Cancer Ther; 2013 Sep; 12(9):1860-73. PubMed ID: 23839309
[TBL] [Abstract][Full Text] [Related]
13. Expanding role of PI5P4Ks in cancer: A promising druggable target.
Arora GK; Palamiuc L; Emerling BM
FEBS Lett; 2022 Jan; 596(1):3-16. PubMed ID: 34822164
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.
Lundquist MR; Goncalves MD; Loughran RM; Possik E; Vijayaraghavan T; Yang A; Pauli C; Ravi A; Verma A; Yang Z; Johnson JL; Wong JCY; Ma Y; Hwang KS; Weinkove D; Divecha N; Asara JM; Elemento O; Rubin MA; Kimmelman AC; Pause A; Cantley LC; Emerling BM
Mol Cell; 2018 May; 70(3):531-544.e9. PubMed ID: 29727621
[TBL] [Abstract][Full Text] [Related]
15. FXR1 regulates transcription and is required for growth of human cancer cells with
Fan Y; Yue J; Xiao M; Han-Zhang H; Wang YV; Ma C; Deng Z; Li Y; Yu Y; Wang X; Niu S; Hua Y; Weng Z; Atadja P; Li E; Xiang B
Elife; 2017 Aug; 6():. PubMed ID: 28767039
[TBL] [Abstract][Full Text] [Related]
16. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L
J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859
[TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
[TBL] [Abstract][Full Text] [Related]
18. Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.
De U; Son JY; Jeon Y; Ha SY; Park YJ; Yoon S; Ha KT; Choi WS; Lee BM; Kim IS; Kwak JH; Kim HS
Food Chem Toxicol; 2019 Jan; 123():492-500. PubMed ID: 30458268
[TBL] [Abstract][Full Text] [Related]
19. Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain.
Noch EK; Yim I; Milner TA; Cantley LC
J Comp Neurol; 2021 Feb; 529(2):434-449. PubMed ID: 32449185
[TBL] [Abstract][Full Text] [Related]
20. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
